Cytocast

Private

BudapestHealthcare & Life Scienceshttps://cytocast.com/

Last Round

Seed

Aug 1, 2023

Total Funding Raised

$2.05M

Company Overview

Cytocast is a biotechnology company that provides a drug discovery platform using computer simulations technology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

in-silico simulationside effect predictiondigital twinAI drug discoverywhole-cell simulationpreclinical safetypredictive toxicologycomputational drug discoverydrug developmentmechanistic simulationTechBioadverse event forecastingdigital biologysystems biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytocast Comps

Public and private peers based on sector, stage, and business model.

Cytocast comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytocast Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Aug 1, 2023
Grant	Sep 26, 2022
Pre Seed	Dec 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Erzsébet Fichó

Chief Operating Officer Product Manager Founder

Founding Team

Attila Csikász-Nagy

Chief Executive Officer

Executive Team

István Reguly

Chief Technology Officer

Executive Team

Bence Keömley-Huszár

Vice President of Engineering, Chief Technology Officer

Executive Team

View all key people

Cytocast Investors

Notable investors and investment history

Cytocast investors
Investor	Rounds
Bonitás Investment Fund Management	Seed
Creative Accelerator	Pre Seed, Seed
FastVentures	Seed
National Research, Development and Innovation Office (NKFIH)	Grant
Zoiros Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 4, 2026
Monthly visitors increased 139% MoM, reaching 2.7K.
Mar 1, 2026
Grew 16% QoQ from 19 to 22 employees.

View all signals

Cytocast Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cytocast Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytocast's valuation, stock price, and market status.

Firmographic Details

HeadquartersBudapest

Employee Range24

Year Founded2019

Last FundingAug 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.